Home › Autism Spectrum Disorder › NCT04322734
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
RecruitingObservational studyHealthy volunteers welcome
Who can join
Up to age 18 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria (ASD): 1. ASD, as defined by either a gold standard measure for ASD diagnosis, the Autism Diagnostic Observation Schedule (ADOS); the Autism Diagnostic Interview-Revised (ADI-R); and/or a comprehensive assessment that is consistent with ASD, in the opinion of the principal investigator. For those the PI believes a prospective diagnosis of ASD is warranted, a formal diagnostic assessment will be scheduled at screening. 2. 0 years through 17 years 11 months of age Inclusion Criteria (TD, MD, Epilepsy, Brain Tumor, Psychiatric) 1\. 0 years to 17 years 11 months of age Exclusion Criteria (All): 1. History of a significant adverse reaction to a prior blood draw 2. In females of reproductive age, pregnancy or plans to become pregnant 3. Any other historical event/information that may, in the opinion of the PI, be a reason to exclude the child from participation.
About the study
The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate.
This study is currently recruiting.
There is no cost for visits or study-related exams.
Sponsor: Southwest Autism Research & Resource Center · Participants: 500 · Started: Dec 13, 2023
Contact the study team
- Richard E Frye, MD, PhD · Phone: 844-ADTFRes
Official record on ClinicalTrials.gov — NCT04322734
Locations in the U.S.
| Arizona | Southwestern Research and Resource Center, Phoenix |
| New York | State University of New York, Downstate, Brooklyn |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.